Brief description: 

The aim of the COVID-19 Data Portal is to facilitate data sharing and analysis, and to accelerate coronavirus research

The COVID-19 Data Portal

An unprecedented number of scientific efforts are taking place worldwide in order to help combat the new coronavirus epidemic (COVID-19). One of the biggest challenges in this fast-moving situation is to share data and findings in a coordinated way, in order to understand the disease and to develop treatments and vaccines.

To address this challenge, EMBL-EBI and partners have has set up the COVID-19 Data Portal, which will bring together relevant datasets submitted to EMBL-EBI and other major centres for biomedical data. The aim is to facilitate data sharing and analysis, and to accelerate coronavirus research.

The COVID-19 Data Portal will enable researchers to upload, access and analyse COVID-19 related reference data and specialist datasets.

The COVID-19 Data Portal will be the primary entry point into the functions of a wider project, the European COVID-19 Data Platform.

The European COVID-19 Data Platform

Rapid and open sharing of data greatly accelerates research and discovery, which is essential to respond to the COVID-19 pandemic. The European Commission and EMBL’s European Bioinformatics Institute (EMBL-EBI), together with EU Member States and research partners such as ELIXIR, are deploying a dedicated European COVID-19 Data Platform that will enable the rapid collection and comprehensive data sharing of available research data from different sources for the European and global research communities. This joint effort is a priority pilot to realise the objectives of the European Open Science Cloud (EOSC).

The European COVID-19 Data Platform will consist of two connected components:

  • SARS-CoV-2 Data Hubs, which will organise the flow of SARS-CoV-2 outbreak sequence data and provide comprehensive open data sharing for the European and global research communities.

    Read more about the Data Hubs >

  • COVID-19 Data Portal, which will bring together and continuously update relevant COVID-19 datasets and tools, will host sequence data sharing and will facilitate access to other SARS-CoV-2 resources.

To rapidly populate the COVID-19 Data Portal, EMBL-EBI will bring together COVID-19 datasets that have been submitted to its public databases, including ENA, UniProt, PDBe, EMDB, Expression Atlas and Europe PMC. The data, which have so far been collated, include genes, protein structures, electron microscopy data and scientific publications.

Engage with this project

Looking to collaborate with us on the European COVID-19 Data Platform?
ecovid19@ebi.ac.uk

To share your data on COVID-19, contact the data curation helpdesk:
virus-dataflow@ebi.ac.uk

This website uses cookies, and the limited processing of your personal data to fu

Main Features: 

The SARS-CoV-2 Data Hubs will form one of the two components of the European COVID-19 Data Platform.

Data Hubs

These will be built upon existing EMBL-EBI infrastructure, and we will offer SARS-CoV-2 Data Hubs to those public health agencies and other scientific groups responsible for generating sequence data from the outbreak at national or regional levels. It is expected that there will ultimately be numerous SARS-CoV-2 Data Hubs with similar configurations in terms of analysis, but different preferred submission tools.

Sequence data in the SARS-CoV-2 Data Hubs will be highly contextualised. Essential metadata, such as sampling tracking identifiers, sampling time, geographical location, method of sampling, health status of host and sequencing platform/strategy, will be captured alongside sequence data. The SARS-CoV-2 Data Hubs will also provide systematic data processing and analysis, visualisation and phylogenetic analysis tools.

Areas of Application: 

Health

Market Trends and Opportunities: 

Rapid and open sharing of data greatly accelerates research and discovery, which is essential to respond to the COVID-19 pandemic. The European Commission and EMBL’s European Bioinformatics Institute (EMBL-EBI), together with EU Member States and research partners such as ELIXIR, are deploying a dedicated European COVID-19 Data Platform that will enable the rapid collection and comprehensive data sharing of available research data from different sources for the European and global research communities.

Customer Benefits: 

The COVID-19 Data Portal will enable researchers to upload, access and analyse COVID-19 related reference data and specialist datasets.

The COVID-19 Data Portal will be the primary entry point into the functions of a wider project, the European COVID-19 Data Platform.

Technological novelty: 

The deployment of a dedicated European COVID-19 Data Platform that will enable the rapid collection and comprehensive data sharing of available research data from different sources for the European and global research communities.

Workflow: 
Published
Platform / Framework

Owner

Ecovid19
United Kingdom of Great Britain and Northern Ireland
Type: 
BDVA member
Contact: 
BDV Reference categories: 
Data Management
Markets: 
COVID-19
Health and Wellness
Readiness Level: 
Keywords: 
COVID-19
Data platform
Data sharing